Cargando…
ECPPF (E2F1, CCNA2, POLE, PPP2R1A, FBXW7) stratification: Profiling high-risk subtypes of histomorphologically low-risk and treatment-insensitive endometrioid endometrial cancer
In endometrial cancer, occult high-risk subtypes (rooted in histomorphologically low-risk disease) with insensitivity to adjuvant therapies impede improvements in therapeutic efficacy. Therefore, we aimed to assess the ability of molecular high-risk (MHR) and low-risk (MLR) ECPPF (E2F1, CCNA2, POLE,...
Autores principales: | Gonzalez-Bosquet, Jesus, Weroha, S. John, Bakkum-Gamez, Jamie N., Weaver, Amy L., McGree, Michaela E., Dowdy, Sean C., Famuyide, Abimbola O., Kipp, Benjamin R., Halling, Kevin C., Yadav, Siddhartha, Couch, Fergus J., Podratz, Karl C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714733/ https://www.ncbi.nlm.nih.gov/pubmed/36454788 http://dx.doi.org/10.1371/journal.pone.0278408 |
Ejemplares similares
-
Prognostic stratification of endometrial cancers with high microsatellite instability or no specific molecular profile
por: Gonzalez-Bosquet, Jesus, et al.
Publicado: (2023) -
Association of a novel endometrial cancer biomarker panel with prognostic risk, platinum insensitivity, and targetable therapeutic options
por: Bosquet, Jesus Gonzalez, et al.
Publicado: (2021) -
CCNA ICND2 :Guía oficial para el exámen de certificación.
por: Odom,Wendell
Publicado: (2008) -
CCNA
por: Valentine, Michael, et al.
Publicado: (2008) -
CCNA voice
por: Bateman, David, et al.
Publicado: (2009)